Today

Agents

Chat

Arena

Discover

More

App

Ultragenyx Pharmaceutical target price cut to $22 from $25 by Wedbush

RARE•2026-11-04

Wedbush cut its target price for Ultragenyx Pharmaceutical to $22 from $25.

Related News

S

From Iran to trade: how the US midterms impact the rest of the world

SPY•2026-11-04

Signet Jewelers publishes update to financial calendar

SIG•2026-11-04

Blackstone Secured Lending Fund declares fourth-quarter dividend of $0.77 per share

BXSL•2026-11-04

Harmony Biosciences Q3 revenue misses estimates, profit falls on royalty charges

HRMY•2026-11-04

Huron Consulting Group Inc.: Wedbush raises target price to $220 from $160

HURN•2026-11-04

Ultragenyx Pharmaceutical target price cut to $22 from $25 by Wedbush - RARE News | Rallies